PGIM Jennison Health Sciences R6 (PHLQX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
47.54
-0.29 (-0.61%)
At close: Dec 30, 2025
8.12%
Fund Assets1.56B
Expense Ratio0.77%
Min. Investment$0.00
Turnover79.00%
Dividend (ttm)5.16
Dividend Yield10.80%
Dividend Growth-5.15%
Payout FrequencyAnnual
Ex-Dividend DateDec 19, 2025
Previous Close47.83
YTD Return20.07%
1-Year Return20.04%
5-Year Return41.23%
52-Week Low34.49
52-Week High48.52
Beta (5Y)n/a
Holdings51
Inception DateJan 27, 2016

About PHLQX

The PGIM Jennison Health Sciences Fund Class R6 is an actively managed sector equity fund aimed at achieving long-term capital appreciation. It focuses on investments in companies within the health sciences sector, including pharmaceuticals, biotechnology, medical devices, and healthcare services. Designed primarily for institutional investors, this fund benefits from a lower expense ratio compared to other share classes. It actively seeks out companies with strong growth potential and innovative products or services, making it a strategic investment option for those looking to capitalize on the rapidly evolving healthcare industry. The fund's diversified portfolio includes a range of healthcare-related companies, positioning it as a key player in the financial market for health sector investments.

Fund Family PGIM Investments
Category Health
Performance Rating Above Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol PHLQX
Share Class Class R6
Index S&P Composite 1500 Health Care TR

Performance

PHLQX had a total return of 20.04% in the past year, including dividends. Since the fund's inception, the average annual return has been 19.14%.

Other Share Classes

These are alternative share classes of the same fund, from the same provider.

SymbolShare ClassExpense Ratio
PHSZXClass Z0.86%
PHLAXClass A1.13%
PJHRXClass R1.48%
PHLCXClass C1.96%

Top 10 Holdings

51.23% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY16.48%
Thermo Fisher Scientific Inc.TMO5.39%
Prudential Govt Money Mkt Fdn/a5.30%
Danaher CorporationDHR5.01%
argenx SEARGX4.62%
UCB SAUCB3.14%
Vertex Pharmaceuticals IncorporatedVRTX2.91%
Neurocrine Biosciences, Inc.NBIX2.90%
AstraZeneca PLCAZN2.80%
UnitedHealth Group IncorporatedUNH2.68%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 19, 2025$5.16365Dec 19, 2025
Dec 20, 2024$5.44419Dec 20, 2024
Dec 20, 2023$1.91322Dec 20, 2023
Dec 20, 2022$0.61624Dec 20, 2022
Dec 20, 2021$14.02528Dec 20, 2021
Dec 20, 2019$1.43164Dec 20, 2019
Full Dividend History